Clinical utility of genetic tests for inherited hypertrophic and dilated cardiomyopathies

Cardiovascular Ultrasound

Volumn 6, Issue , 2008, Pages

  Colombo, Maria Giovanna ^a   Botto, Nicoletta ^a   Vittorini, Simona ^a   Paradossi, Umberto ^a   Andreassi, Maria Grazia ^a  

^a INSTITUTE OF CLINICAL PHYSIOLOGY   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOSOMAL INHERITANCE; CONGESTIVE CARDIOMYOPATHY; DNA DETERMINATION; FAMILY HISTORY; GENE FREQUENCY; GENE MUTATION; GENETIC ANALYSIS; GENETIC COUNSELING; GENETIC LINKAGE; GENETIC SCREENING; GENOTYPE PHENOTYPE CORRELATION; HIGH RISK POPULATION; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; REVIEW; GENETIC PREDISPOSITION; GENETICS; METHODOLOGY; NUCLEOTIDE SEQUENCE; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY; SINGLE NUCLEOTIDE POLYMORPHISM;

CARDIOMYOPATHY, DILATED; CARDIOMYOPATHY, HYPERTROPHIC; DNA MUTATIONAL ANALYSIS; GENETIC PREDISPOSITION TO DISEASE; GENETIC SCREENING; HUMANS; POLYMORPHISM, SINGLE NUCLEOTIDE; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 58749086556     PISSN: None     EISSN: 14767120     Source Type: Journal    
DOI: 10.1186/1476-7120-6-62     Document Type: Review

References (39)

1. Implications of the human genome project for medical science. FS Collins VA McKusick, JAMA 2001 285 540 544 10.1001/jama.285.5.540 11176855
2. Genetic diagnosis and testing in clinical practice. E McPherson, Clin Med Res 2006 4 123 129 16809405
3. A Vision for the Future of Genomics Research. FS Collins ED Green AE Guttmacher MS Guyer, Nature 2003 422 835 47 10.1038/nature01626 12695777
4. Genetic Testing and Genetic Counseling in Cardiovascular Genetic Medicine: Overview and Preliminary Recommendations. L Cowan A Morales J Dagua R Hershberger, Congest Heart Fail 2008 14 97 105 10.1111/j.1751-7133.2008.08217.x 18401220
5. Genetic testing in cardiovascular disease. NH Robin PB Tabereaux R Benza BR Korf, J Am Coll Cardiol 2007 50 727 37 10.1016/j.jacc.2007.05.015 17707176
6. Family history: an essential tool for cardiovascular genetic medicine. A Morales J Cowan J Dagua RE Hershberger, Congest Heart Fail 2008 14 37 45 10.1111/j.1751-7133.2008.08201.x 18256568
7. Family history: the three-generation pedigree. DJ Wattendorf DW Hadley, Am Fam Physician 2005 72 441 448 16100858
8. American College of Cardiology/European Society of Cardiology: Clinical expert consensus document on hypertrophic cardiomyopathy. A report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the European Society of Cardiology Committee for Practice Guidelines. BJ Maron WJ McKenna GK Danielson LJ Kappenberger HJ Kuhn CE Seidman PM Shah WH Spencer 3rd P Spirito FJ Ten Cate ED Wigle Task Force on Clinical Expert Consensus Documents. American College of Cardiology; Committee for Practice Guidelines. European Society of Cardiology. Task Force on Clinical Expert Consensus Documents. American College of Cardiology; Committee for Practice Guidelines; European Society of Cardiology, J Am Coll Cardiol 2003 42 1687 1713 10.1016/S0735-1097(03)00941-0 14607462
9. Contemporary definitions and classification of the cardiomyopathies: an American Heart Association Scientific Statement from the Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interdisciplinary Working Groups; and Council on Epidemiology and Prevention. BJ Maron JA Towbin G Thiene C Antzelevitch D Corrado D Arnett AJ Moss CE Seidman JB Young American Heart Association; Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interdisciplinary Working Groups; Council on Epidemiology and Prevention, Circulation 2006 113 1807 16 10.1161/CIRCULATIONAHA.106.174287 16567565
10. Familial hypertrophic cardiomyopathy: clinical features, molecular genetics and molecular genetic testing. MR Taylor E Carniel L Mestroni, Exp Rev Mol Diagn 2004 4 99 113 10.1586/14737159.4.1.99
11. A contemporary approach to hypertrophic cardiomyopathy. CY Ho CE Seidman, Circulation 2006 113 858 62 10.1161/CIRCULATIONAHA.105.591982
12. Genetics of hypertrophic cardiomyopathy: one, two, or more diseases? MJ Bos SR Ommen MJ Ackerman, Curr Opin Cardiol 2007 22 193 9 10.1097/HCO. 0b013e3280e1cc7f 17413275
13. Hypertrophic cardiomyopathy: distribution of disease genes, spectrum of mutations, and implications for a molecular diagnosis strategy. P Richard P Charron L Carrier C Ledeuil T Cheav C Pichereau A Benaiche R Isnard O Dubourg M Burban JP Gueffet A Millaire M Desnos K Schwartz B Hainque M Komajda EUROGENE Heart Failure Project, Circulation 2003 107 2227 32 10.1161/01.CIR.0000066323. 15244.54 12707239
14. Epidemiology of hypertrophic cardiomyopathy-related death: revisited in a large non-referral-based patient population. BJ Maron I Olivotto P Spirito SA Casey P Bellone TE Gohman KJ Graham DA Burton F Cecchi, Circulation 2000 102 858 64 10952953
15. The genetic basis for cardiomyopathy: from mutation identification to mechanistic paradigms. JC Seidman C Seidman, Cell 2001 104 557 67 10.1016/S0092-8674(01)00242-2 11239412
16. Proposal for contemporary screening strategies in families with hypertrophic cardiomyopathy. BJ Maron JG Seidman CE Seidman, J Am Coll Cardiol 2004 44 2125 32 10.1016/j.jacc.2004.08.052 15582308
17. Glycogen storage diseases presenting as hypertrophic cardiomyopathy. M Arad BJ Maron JM Gorham WH Johnson Jr JP Saul AR Perez-Atayde P Spirito GB Wright RJ Kanter CE Seidman JG Seidman, N Engl J Med 2005 352 362 72 10.1056/NEJMoa033349 15673802
18. Generalized lysosome-associated membrane protein-2 defect explains multisystem clinical involvement and allows leukocyte diagnostic screening in Danon disease. M Fanin AC Nascimbeni L Fulizio M Spinazzi P Melacini C Angelini, Am J Pathol 2006 168 1309 20 16565504 10.2353/ajpath.2006.050646
19. Clinical and genetic issues in familial dilated cardiomyopathy. EL Burkett RE Hershberger, J Am Coll Cardiol 2005 45 969 981 10.1016/j.jacc.2004. 11.066 15808750
20. Genetics and cardiomyopathy: Where are we now? RT Murphy RC Starling, Cleve Clin J Med 2005 72 465 483 16018289
21. Mutations in sarcomere protein genes as a cause of dilated cardiomyopathy. M Kamisago SD Sharma SR DePalma S Solomon P Sharma B McDonough L Smoot MP Mullen PK Woolf ED Wigle JG Seidman CE Seidman, N Engl J Med 2000 343 1688 96 10.1056/NEJM200012073432304 11106718
22. Large-scale mutation screening in patients with dilated or hypertrophic cardiomyopathy: a pilot study using DGGE. R Zeller BT Ivandic P Ehlermann O Mucke C Zugck A Remppis E Giannitsis HA Katus D Weichenhan, J Mol Med 2006 84 682 91 10.1007/s00109-006-0056-2 16715312
23. Human laminopathies: nuclei gone genetically awry. BC Capell FS Collins, Nat Rev Genet 2006 7 940 952 10.1038/nrg1906 17139325
24. Laminopathies: a wide spectrum of human disease. HJ Worman G Bonne, Exp Cell Res 2007 313 2121 2133 10.1016/j.yexcr.2007.03.028 17467691
25. Missense mutations in the rod domain of the lamin A/C gene as causes of dilated cardiomyopathy and conduction-system disease. D Fatkin C MacRae T Sasaki MR Wolff M Porcu M Frenneaux J Atherton HJ Vidaillet Jr S Spudich U De Girolami JG Seidman C Seidman F Muntoni G Müehle W Johnson B McDonough, N Engl J Med 1999 341 1715 24 10.1056/NEJM199912023412302 10580070
26. Lamin A/C gene mutation associated with dilated cardiomyopathy with variable skeletal muscle involvement. G Brodsky F Muntoni S Miocic G Sinagra C Sewry L Mestroni, Circulation 2000 101 473 6 10662742
27. High incidence of sudden death with conduction system and myocardial disease due to lamins A and C gene mutation. HM Becane G Bonne S Varnous A Muchir V Ortega EH Hammouda JA Urtizberea T Lavergne M Fardeau B Eymard S Weber K Schwartz D Duboc, Pacing Clin Electrophysiol 2000 23 1661 6 10.1046/j.1460-9592.2000.01661.x 11138304
28. Novel lamin A/C mutations in two families with dilated cardiomyopathy and conduction system disease. PM Jakobs E Hanson KA Crispell W Toy H Keegan K Schilling TB Icenogle M Litt RE Hershberger, J Card Fail 2001 7 249 56 10.1054/jcaf.2001.26339 11561226
29. A novel lamin A/C mutation in a family with dilated cardiomyopathy, prominent conduction system disease, and need for permanent pacemaker implantation. RE Hershberger E Hanson PM Jakobs H Keegan K Coates S Bousman M Litt, Am Heart J 2002 144 1081 6 10.1067/mhj.2002.126737 12486434
30. Autosomal dominant dilated cardiomyopathy with atrioventricular block: a lamin A/C defect-related diseas. E Arbustini A Pilotto A Repetto A Repetto M Grasso A Negri M Diegoli C Campana L Scelsi E Baldini A Gavazzi L Tavazzi, J Am Coll Cardiol 2002 39 981 90 10.1016/S0735-1097(02)01724-2 11897440
31. High yield of LMNA mutations in patients with dilated cardiomyopathy and/or conduction disease referred to cardiogenetics outpatient clinics. JP van Tintelen RM Hofstra H Katerberg T Rossenbacker AC Wiesfeld GJ du Marchie Sarvaas AA Wilde IM van Langen EA Nannenberg AJ van der Kooi M Kraak IC van Gelder DJ van Veldhuisen Y Vos MP van den Berg Working Group on Inherited Cardiac Disorders, line 27/50, Interuniversity Cardiology Institute of The Netherlands, Am Heart J 2007 154 1130 9 10.1016/j.ahj.2007.07.038 18035086
32. Identification of mutational hot spots in LMNA encoding lamin A/C in patients with familial dilated cardiomyopathy. A Perrot S Hussein V Ruppert HH Schmidt MS Wehnert NT Duong MG Posch A Panek R Dietz I Kindermann M Böhm A Michalewska-Wludarczyk A Richter B Maisch S Pankuweit C Ozcelik, Basic Res Cardiol 2008 Sep 15 18795223
33. Familial dilated cardiomyopathy and isolated left ventricular noncompaction associated with lamin A/C mutations. M Hermida-Prieto L Monserrat A Castro-Beiras R Laredo R Soler J Peteiro E Rodríguez B Bouzas N Alvarez J Mũiz M Crespo-Leiro, Am J Cardiol 2004 94 50 54 10.1016/j.amjcard.2004. 03.029 15219508
34. Novel mutations in the lamin A/C gene in heart transplant recipients with end stage dilated cardiomyopathy. S Kärkkäinen E Reissell T Heliö M Kaartinen P Tuomainen L Toivonen J Kuusisto M Kupari MS Nieminen M Laakso K Peuhkurinen, Heart 2006 92 524 526 10.1136/hrt.2004.056721 16537768
35. Lamin A/C mutations associated with familial and sporadic cases of dilated cardiomyopathy in Koreans. K Song MP Dube J Lim I Hwang I Lee JJ Kim, Exp Mol Med 2007 39 114 120 17334235
36. Meta-analysis of clinical characteristics of 299 carriers of LMNA gene mutations: Do lamin A/C mutations portend a high risk of sudden death? JH Van Berlo WG de Voogt AJ van der Kooi JP van Tintelen G Bonne RB Yaou D Duboc T Rossenbacker H Heidbüchel M de Visser HJ Crijns YM Pinto, J Mol Med 2005 83 79 83 10.1007/s00109-004-0589-1 15551023
37. Long-term outcome and risk stratification in dilated cardiolaminopathies. M Pasotti C Klersy A Pilotto N Marziliano C Rapezzi A Serio S Mannarino F Gambarin V Favalli M Grasso M Agozzino C Campana A Gavazzi O Febo M Marini M Landolina A Mortara G Piccolo M Viganò L Tavazzi E Arbustini, J Am Coll Cardiol 2008 52 1250 60 10.1016/j.jacc.2008.06.044 18926329
38. Diagnostic yield, interpretation, and clinical utility of mutation screening of sarcomere encoding genes in Danish hypertrophic cardiomyopathy patients and relatives. PS Andersen O Havndrup L Hougs KM Sørensen M Jensen LA Larsen P Hedley AR Bie Thomsen J Moolman-Smook M Christiansen H Bundgaard, Hum Mutat 19035361
39. Identification of a mutation in the beta-cardiac myosin heavy chain gene in a family with hypertrophic cardiomyopathy. S Al-Mahdawi S Chamberlain J Cleland P Nihoyannopoulos D Gilligan J French L Choudhury R Williamson C Oakley, Br Heart J 1993 69 136 41 8435239 10.1136/hrt.69.2.136